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Background: To evaluate the efficacy of combined treatment with bone marrow mesenchymal stem cell (BMSC)
transplantation and methylprednisolone (MP) to treat paraquat (PQ)-induced acute lung injury.
Materials and methods: A total of 102 female rats were randomly divided into five groups: PQ, BMSC, MP, BMSC
+ MP and normal control. After 14 days of PQ poisoning, the survival of rats, wet/dry weight ratio of lung tissue,
serum levels of tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6, IL-10, malondialdehyde (MDA) and
superoxidase dismutase (SOD), and the expression of nuclear factor (NF)-кB p65 in lung tissue were determined.
Results: Rats in BMSC and BMSC + MP groups survived. BMSC transplantation significantly decreased the wet/dry
weight ratio of lung tissue, down-regulated NF-кB p65 expression in lung tissue, lowered serum levels of TNF-a,
IL-1b, IL-6 and MDA, and increased serum levels of IL-10 and SOD. These changes were particularly significant on
days 7–14 after PQ poisoning. The above changes were more significant in the MP group on days 1–3 after PQ
poisoning, compared with those of the BMSC group. However, the BMSC + MP group showed more significant
changes on days 1–14 after PQ poisoning than those of both BMSC and MP groups.
Conclusions: MP inhibits the inflammatory response, reduces the products of lipid peroxidation and promotes
survival of transplanted BMSC, thus improving the intermediate and longer term efficacy of BMSC transplantation
for treatment of PQ-induced lung injury.
Introduction
Paraquat (PQ) is an organic heterocyclic herbicide and
defoliant agent used worldwide. However, PQ is highly
toxic to humans and animals and no effective antidote is
available, which causes a high mortality rate[1,2]. Large
scale clinical observations and experimental research have
shown that the lung is the main target organ for PQ poi-
soning. This is because pulmonary cells actively take up
and accumulate PQ [3-5]. Although patient survival is
enhanced by comprehensive therapy, mortality is not
obviously improved. Therefore, we are in an embarrassing
situation: clinical treatment is still difficult even though
the mechanism of PQ poisoning is being studied in more
and more depth. Therefore, identifying new therapeutic
strategies may help to open this bottleneck. Bone marrow
mesenchymal stem cells (BMSC) are an ideal cell source
for tissue repair and are increasingly used to treat lung
injury. It has been demonstrated that BMSCs migrate into
injured lung and, either directly or indirectly, repair
damaged lung tissue [6-8]. In this study, BMSC transplan-
tation was combined with methylprednisolone (MP) to
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rats (2 male, 120g±20g and 102 female, 200g±20g) were
provided by the Experiment Animal Center of the Fourth
Military Medical University(Xi’an, China) . 200g/L PQ
solution dichloride was obtained from Tianjin Shipule
Agriculture Pesticides Technology & Development Inc
(Tianjin, China). MP was obtained from Pfizer Inc (New
York, USA) . Fluorescein isothiocyanate(FITC)-conjugated
anti-mouse CD34, CD45, CD44 and CD166 antibodies
were obtained from Biolegend(San Francisco, USA). The
nucleoprotein extraction kit was obtained from Promega
(Madison, USA), the NF-кBp65 polyclonal antibody from
Santa Cruz (California, USA). The rat Interleukin-1b (IL-
1b) and Tumor necrosis factor-a(TNF-a) and Interleukin-
6(IL-6) and Interleukin-10(IL-10) ELISA kits from Sigma
(St.Louis,USA). Malonaldehyde (MDA) and superoxide
dismutase (SOD) kits were obtained from the Nanjing
jiancheng Bioengineering Institute(Nanjing, China).
Isolation, culture and identification of BMSC
Male rats were sacrificed by cervical dislocation and the
femur and tibia were harvested. The bone marrow cells
were gently resuspended into single cells. BMSCs were
isolated by Percoll gradient centrifugation, and resus-
pended in Dulbecco’s modified Eagle’s medium (DMEM)-
F12 supplemented with 10% fetal bovine serum Cells were
seeded in 25 cm2 culture flasks at 1 × 105 cells/cm2 and
maintained at 37°C with 5% CO2 in a humidified incuba-
tor. Culture medium was exchanged after 48 h and then
every 2–3 days. Cells were cultured to 80–90% confluence
and then digested with 0.25% trypsin containing 0.02%
EDTA for 1 min. Then, cells were centrifuged, resus-
pended and passaged at a 1:3 ratio. Third passage cells
were tested using flow cytometry for cell surface expres-
sion of CD34, CD45, CD44 and CD166 [9].
Grouping
Female SD rats were randomly divided into five groups: 1)
PQ group (n = 24): PQ solution was intraperitoneally
injected at a dose of 20 mg/kg. 2). BMSC group (n = 24):
BMSCs (0.5 mL, 1 × 107 cells) were injected via the tail vein
at 6 h after PQ injection. 3). MP group (n = 24): MP
(20 mg/kg) was administered via the tail vein once a day for
2 consecutive days at 2 h after PQ injection. 4). BMSC +
MP group (n = 24): BMSCs and MP were administered as
described above. 5) Normal control group (n = 6): rats were
intraperitoneally injected with 0.9% saline.
Macro observation
Animals were observed for general activity, feeding and
survival for 14 days after PQ poisoning.
Wet/dry weight ratio of lung tissue
At 1, 3, 7 and 14 days post-injection, the right lung was
isolated and the trachea ligated. After blotted off the
blood and other contaminants, the wet weight was mea-
sured. Then the lung was dried in a 70°C oven for 72 h
and the dry weight was measured. The lung wet/dry
weight ratio was calculated.
Determination of cytokine levels
Plasma was collected on days 1,3,7 and 14 post-injection
and the concentrations of TNF-a, IL-1b, IL-6, IL-10,
MDA and SOD measured by respective ELISAs kits.
Nucleoprotein extraction and Measurement of NF-кBp65
expression
On days 1, 3, 7 and 14 post-injection, the left-sided lung
tissues were isolated, and rinsed with cold phosphate buf-
fer solution (PBS). Nucleoprotein lytic/extraction buffer
solution A (2 ml) was added and the tissues incubated on
ice for 30 min. The tissue was then homogenized, mixed
with 500μl of 10% Nonidet P-40 and centrifuged. The pre-
cipitate was rinsed twice with cold PBS and the suspension
was discarded. Nucleoprotein extraction/lytic solution B
(2 mL) was added to the precipitate on ice for 30 min and
the solution centrifuged again to harvest the nucleopro-
teins. Nucleoproteins (10μg) were measured by western
blotting. The images were scanned using a gray-scale scan-
ner and the averaged gray values were used to determine
the NF-кBp65 expression level.
Statistical analysis
All data were statistically analyzed by SPSS 11.5 software
and expressed as mean±standard deviation. The 2-group
comparison were performed with t-test. P<0.05 was con-
sidered statistically significant.
Results
In vitro culture and identification of BMSC
Adherent cells initially showed round morphology and
became spindle- or polygonal-shaped after 3–5 days.
Primary cells proliferated as colonies and reached 80%
confluence after 10–12 days. Cells showed accelerated
proliferation after passaging and were mostly spindle-
shaped, with a small portion of polygonal-shaped cells.
Flow cytometry showed that 69.4% of 3rd generation
cells expressed CD44, 80.7% expressed CD166, and the
expression of CD34 and CD45 was absent, indicating
that adherent cells were BMSC.
General conditions and survival of rats
In the PQ group, rats showed reduced activities and feed-
ing, and an increased respiratory rate. Mean survival time
was 9.6 ± 1.8 days, ranging from 8–12 days. The MP
group did not develop these symptoms until day 3, and
the mean survival time was 12.1 ± 1.3 days, ranging from
10–13 days. Therefore, data from the both groups could
not be obtained on day 14 after PQ poisoning. All rats in
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BMSC group and BMSC + MP group survived up to day
14 after PQ poisoning, and the symptoms in BMSC +
MP group were significantly improved compared with
those of the BMSC group.
Wet/dry weight ratio of lung tissue
The wet/dry weight ratio of lung tissue in the PQ group
was significantly increased compared with that of the
control group on day 7 after PQ poisoning (P < 0.01).
The wet/dry weight ratio of lung tissue in the BMSC
group was similar to that of the PQ group on days 1–3
(P > 0.05), but was significantly decreased compared
with that of the PQ group on day 7 (P < 0.01). On days
1–7 after PQ poisoning, the wet/dry weight ratio of lung
tissue in the MP group was significantly lower than that
of the BMSC group (P < 0.05). The wet/dry weight ratio
of lung tissue in the BMSC + MP group was similar to
that of the MP group on day 1 (P > 0.05), but was sig-
nificantly lower than that of the MP group on days 3–7
(P < 0.01). On days 1–14 after PQ poisoning, the wet/
dry weight ratio of lung tissue in the BMSC + MP
group was significantly lower than that of the BMSC
group (P < 0.01) (Table 1).
Plasma levels of TNF-a, IL-1b, IL-6 and IL-10
Plasma levels of TNF-a, IL-1b, IL-6 and IL-10 in the PQ
group were significantly elevated on day 1 after PQ poi-
soning (P < 0.01), compared with that of the control
group. On days 1–14 after PQ poisoning, plasma levels of
TNF-a, IL-1b and IL-6 in the BMSC group were signifi-
cantly lowered compared with those of the PQ group, and
particularly on days 3 and 7 (P < 0.01). On day 1 after PQ
poisoning, IL-10 level in the BMSC group was similar to
that of the PQ group (P > 0.05), but was significantly
higher than that of the PQ group on day 3 (P < 0.01). The
significantly lowered TNF-a, IL-1b and IL-6 levels, and a
significantly elevated IL-10 level were found in the MP
group compared with those of the BMSC group on day 1
after PQ poisoning (P < 0.01). The significantly lowered
TNF-a, IL-1b and IL-6 levels, and a significantly elevated
IL-10 level were found in the BMSC + MP group com-
pared with those of the MP group and the BMSC group
on day 7 (P < 0.01). (Table 2).
Plasma levels of MDA and SOD
Plasma levels of MDA in the PQ group were signifi-
cantly elevated, and SOD levels were significantly
decreased compared with those of the control group
(P < 0.01). On days 3–7 after PQ poisoning, the signifi-
cantly lowered MDA levels, and a significantly elevated
SOD level were found in the BMSC group, compared
with those of the PQ group (P < 0.01).Plasma levels of
MDA and SOD in the MP group were significantly low-
ered and elevated, respectively, on day 1 compared with
those of the BMSC group (P < 0.01). MDA and SOD
levels in the BMSC + MP group were significantly low-
ered and elevated, respectively, compared with those of
BMSC group and MP group on days on days 3–7 (P <
0.01) (Table 3).
Expression of NF-кB p65 in lung tissue
NF-кB p65 expression in lung tissue from the PQ group
was significantly elevated and peaked on day 3 after PQ
poisoning, compared with that of the control group (P <
0.01). NF-кB p65 expression from the BMSC group was
lowered on day 1 (P < 0.01), compared with that from the
PQ group. NF-кB p65 expression in the MP group was
significantly lowered on days 1–3, compared with that in
the BMSC group (P < 0.01), but was similar to that from
the BMSC group on day 7 (P > 0.05). The BMSC + MP
group showed similar expressions of NF-кB p65, com-
pared with those of the MP group on days 1–3 (P > 0.05),
but were significantly lower than those of the BMSC
group (P < 0.01). In addition, NF-кB p65 expressions in
the BMSC + MP group on days 7-14 after PQ poisoning
were lower than those in the BMSC group (P < 0.05)
(Table 4).
Discussion
Alveolar cells actively uptake and accumulate PQ causing
severe lung injury. The consensus of the poisoning
mechanism is changes in redox potential. PQ activates
NF-кB and promotes the expression and release of early
inflammatory mediators. In addition, PQ produces large
amounts of oxygen free radicals, induces the production of
lipid peroxides and causes direct damage to major cell
components [10-12]. Dinis-Oliveira et al [13] found that
NF-кB is constantly elevated within 96 h after intraperito-
neal injection of PQ, which is consistent with the findings
of this study. We found that NF-кB is an oxidation-stress
sensitive transcription factor in PQ-induced lung injury.
Significant and sustained activation of NF-кB during days
1-7 after PQ poisoning causes the release of inflammatory
cytokines(TNF-a, IL-1b, IL-6, IL-10), initiating a cascade
effect and resulting in uncontrollable lung inflammation.
In addition, large amounts of MDA were produced, which
reduced free radical scavenger SOD and caused cell
damage.
Table 1 Wet/dry weight ratio of rat lung tissue (n = 6)
Groups 1d 3d 7d 14d
PQ 4.51 ± 0.18a 5.52 ± 0.21a 7.62 ± 0.26a
BMSC 4.51 ± 0.34b 5.49 ± 0.42b 6.15 ± 0.42c 5.65 ±0.57
MP 4.42 ± 0.29d 5.32 ± 0.37d 5.94 ± 0.28d
BMSC + MP 4.40 ± 0.51ef 5.18 ± 0.19eg 4.79 ± 0.31eg 4.71 ±0.25 e
Normal control 4.32 ± 0.31
Note: a P < 0.01, vs. normal control group; bP > 0.05, c P < 0.01, vs. PQ group;
d P < 0.05, e P < 0.01, vs. BMSC group; fP > 0.05, g P < 0.01, vs. MP group.
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Stem cell therapy has gained a great amount of atten-
tion in basic research and clinical application for treat-
ment of lung injuries. Rojas et al. [14] found that
bleomycin induces severe lung injury after ablation of
mouse bone marrow, and exogenous BMSC transplanta-
tion significantly reduces lung inflammation. We found
that BMSC transplantation significantly reduced NF-кB
p65 expression in lung tissue after PQ poisoning, thus
reducing the serum levels of TNF-a, IL-1b and IL-6
resulting in elevated IL-10 levels. In addition, transplan-
tation of BMSCs also reduced MDA levels and SOD con-
sumption, thereby lowering the wet/dry weight ratio of
lungs after PQ poisoning. It has been suggested that
BMSC reduce edema and exudation in lung injury, inhi-
bit the release of inflammatory mediators and lipid per-
oxidation, attenuate inflammation and reduce cell
damage. We also found that BMSC transplantation
showed relatively weak efficacy in reducing NF-кB p65
on day 1 after PQ poisoning, which was consistent with
the serum levels of TNF-a, IL-1b, IL-6 and IL-10, sug-
gesting that BMSCs did not efficiently inhibit the early
inflammatory response. We speculate that the grafted
BMSCs required time to be fully functional after trans-
plantation and therefore were not effective during days
1–3 after PQ poising. However, BMSC transplantation
maintained constant protection during days 7–14 after
PQ poisoning.
A number of cytokines and inflammatory mediators
attract transplanted BMSC, but are also toxic and may
compromise the survival of BMSC. It has been shown
that TNF-a neutralization decreases the incidence of
lung injury in mice after bone marrow transplantation
[15,16]. High-dose MP is widely used to treat PQ poison-
ing because of its potent anti-inflammatory effects and
ability to improve early lung injury. However, the use of
corticosteroids does not reduce mortality after PQ poi-
soning [17]. In this study, we showed that during days
1–3 after PQ poisoning, treatment with MP alone was
superior to that of BMSC transplantation to reduce NF-
кB p65 expression in lung tissue, lower serum levels of
IL-1b, TNF-, and IL-6, increase IL-10 levels, inhibit
MDA production and SOD consumption and lower the
wet/dry weight ratio of lungs. However, the efficacy of
MP to treat lung injury gradually decreased on days 1–7
Table 2 Plasma levels of cytokines ( ng/L, n = 6)
Group Post-poisoning day TNF-a IL-1b IL-6 IL-10
PQ 1 83.13 ± 10.29 a 30.25 ± 4.68 a 35.47 ± 2.31 a 18.62 ± 5.46 a
3 121.51 ± 10.85 a 48.90 ± 4.62 a 98.15 ± 9.44 a 47.86 ± 7.51 a
7 245.63 ± 12.11 a 102.63 ± 8.71 a 145.61 ± 15.38 a 66.24 ± 5.83 a
14
BMSC 1 79.66 ± 8.31 c 21.05 ± 6.47 c 31.37 ± 5.42 d 18.17 ± 4.63 b
3 105.35 ± 8.32 c 43.11 ± 5.15 c 82.40 ± 7.16 c 59.36 ± 7.27 c
7 144.84 ± 10.73 c 68.78 ± 4.32 c 121.27 ± 9.54 c 83.42 ± 8.03 c
14 65.20 ± 6.64 21.89 ± 3.56 a 84.53 ± 9.07 a 108.05 ± 10.16 a
MP 1 51.17 ± 7.33 e 15.62 ± 4.81 e 19.28 ± 8.66 e 29.75 ± 8.09 e
3 89.15 ±8.65 e 31.72 ±6.18 e 70.50 ±8.13 e 65.39 ±5.24
7 125.63± 10.44e 50.64 ±5.74 e 118.69 ±10.37 85.17 ±7.36
14
BMSC + MP 1 50.43 ± 9.61 ef 13.53 ± 4.17 ef 17.11 ± 5.36 ef 27.91 ± 6.39 ef
3 67.47 ±9.25 e 29.56 ±4.52 ef 71.73 ±8.25 ef 70.69 ±10.42 e
7 71.84 ±8.11 eg 35.18 ±4.83 eg 103.68 ±7.70 eg 92.38 ±6.17 eg
14 49.11 ±7.62 e 14.56 ±2.95 e 49.27 ±10.34 e 117.41± 8.82 e
Normal control 32.08 ± 3.13 10.16 ± 2.56 8.70 ± 0.93 10.04 ± 1.96
Note: a P < 0.01, vs. normal control group; bP > 0.05, c P < 0.01, vs. PQ group; d P < 0.05, e P < 0.01, vs. BMSC group; fP > 0.05, g P < 0.01, vs. MP group.
Table 3 Plasma levels of MDA and SOD (mean ± SD, n = 6)
Group MDA (nmol/ml) SOD (U/ml)
1d 3d 7d 14d 1d 3d 7d 14d
PQ 4.03 ±0.61 a 4.65 ±0.78 a 5.07 ±0.64 a 287.66 ±11.53 a 246.32 ±16.31 a 212.58 ±19.22 a
BMSC 3.97 ±0.70 b 4.32 ±0.48 c 4.16 ±0.81 c 3.63±0.56 285.17 ±13.69 b 261.24 ±20.74 c 269.74 ±15.64 c 284.42± 17.56
MP 3.82 ±0.58 d 4.49 ±0.46 4.06 ±0.62 294.52 ±10.14 d 265.43 ±15.26 280.15 ±14.58
BMSC + MP 3.78 ±0.74 4.20 ±0.29 de 3.79 ±0.51 de 3.31±0.68 292.38 ±9.06 278.66 ±11.84 de 302.37 ±10.11 de 304.15± 10.63
Normal control 3.06 ± 0.24 308.29 ± 18.83
Note: a P < 0.01, vs. normal control group; bP > 0.05, c P < 0.01, vs. PQ group; d P < 0.01, vs. BMSC group; e P < 0.01, vs. MP group.
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after PQ poisoning, which may explain why high-dose
MP improves the symptoms of PQ poisoning, but does
not reduce mortality. The efficacy of BMSC transplanta-
tion combined with MP for the treatment of PQ-induced
lung injury was investigated in this study. We found that
combination with MP improves the relatively poor effi-
cacy of BMSC transplantation for the treatment of lung
injury during days 1–3 after PQ poisoning. MP inhibited
the inflammatory response, reduced the products of lipid
peroxidation and promoted the survival of BMSC, thus
improving the intermediate and longer term efficacy of
BMSC transplantation to treat PQ-induced lung injury.
Conclusions
In summary, the combination of BMSC transplantation
and MP shows an improved protective effect in PQ-
induced acute lung injury. However, the mechanism of
PQ poisoning are complicated and remain unclear.
Further investigation is needed to understand the effects
of BMSCs in acute lung injury.
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Table 4 Gray values for NF-кB p65 expression in lung tissue (mean ± SD, n = 5)
Group 1d 3d 7d 14d
PQ 139.54 ± 12.46a 188.78 ± 17.73a 140.49 ± 9.21a
BMSC 125.32 ± 10.63b 146.56 ± 12.55b 101.84 ± 7.45b 95.77 ± 8.12
MP 116.47 ± 8.91 c 127.82 ± 10.39c 103.37 ± 11.44e
BMSC + MP 115.15 ± 10.48cf 125.16 ± 9.83cf 96.41 ± 12.32d 89.75 ± 7.60d
Normal control 82.36 ± 6.53
Note: a P < 0.01, vs. normal control group; bP < 0.01, vs. PQ group; c P < 0.01, d P < 0.05, e P > 0.05, vs. BMSC group; fP > 0.05, MP group.
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